
Rheb inhibitor NR1
CAS No. 2216763-38-9
Rheb inhibitor NR1( —— )
Catalog No. M33480 CAS No. 2216763-38-9
Rheb inhibitor NR1 is a selective mTORC1 inhibitor that suppresses the phosphorylation of T389pS6K1 and enhances the phosphorylation of S473pAKT.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 128 | Get Quote |
![]() ![]() |
5MG | 188 | Get Quote |
![]() ![]() |
10MG | 312 | Get Quote |
![]() ![]() |
25MG | 609 | Get Quote |
![]() ![]() |
50MG | 915 | Get Quote |
![]() ![]() |
100MG | 1512 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameRheb inhibitor NR1
-
NoteResearch use only, not for human use.
-
Brief DescriptionRheb inhibitor NR1 is a selective mTORC1 inhibitor that suppresses the phosphorylation of T389pS6K1 and enhances the phosphorylation of S473pAKT.
-
DescriptionRheb inhibitor NR1 is a Rheb inhibitor with an IC50 of 2.1?μM in the Rheb-IVK assay. Rheb inhibitor NR1 can directly bind Rheb in the switch II domain and selectively inhibit the activation of mechanistic target of rapamycin complex 1 (mTORC1). Rheb inhibitor NR1 inhibits the phosphorylation of mTORC1 driven T389pS6K1 and increases the phosphorylation of S473pAKT in a dose-dependent manner. Rheb inhibitor NR1 does not influence mTORC2 activity.(Rheb-IVK:Rheb-dependent mTORC1 kinase activity)
-
In VitroCell Viability Assay Cell Line:Jurkat cells Concentration:1, 3 and 10 μM Incubation Time:48 h Result:Effectively reduced the size of Jurkat cells in a dose-dependent manner.Western Blot Analysis Cell Line:MCF-7, TRI102 and PC3 cells Concentration:0.37, 1.1, 3.3, 10 and 30 μM Incubation Time:90 min for MCF-7 and TRI102; 24 h for PC3 Result:Inhibited the phosphorylation of T389pS6K1 and increased the phosphorylation of S473pAKT in a dose-dependent manner.Western Blot Analysis Cell Line:MCF-7 Concentration:1, 3, 10 and 30 μM Incubation Time:2.5 h (then labeled the cells with an 35S-Met labeling mix for 30?min)Result:Dose-dependently reduced protein synthesis.
-
In VivoAnimal Model:Male C57BL/6 mice (6-7 weeks; fast for 16 hours) Dosage:30 mg/kg Administration:IP; single dosage Result:Sustained over 5?μM for 2?h.Significantly reduced mTORC1 activity in both kidney and skeletal muscle, and exhibited a clear band shift for T37/464E-BP1 in skeletal muscle.
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetmTOR
-
RecptormTOR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2216763-38-9
-
Formula Weight578.3
-
Molecular FormulaC25H19BrCl2N2O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (86.46 mM; Ultrasonic )
-
SMILESCN(C)C(=O)c1ccc(Cn2c(cc3c(Br)cc(Sc4ccc(Cl)c(Cl)c4)cc23)C(O)=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mahoney SJ, et al. A small molecule inhibitor of Rheb selectively targets mTORC1 signaling. Nat Commun. 2018 Feb 7;9(1):548.?
molnova catalog



related products
-
Cbz-B3A
Cbz-B3A is a potent inhibitor of mTORC1 signalling, inhibits phosphorylation of eIF4E-binding protein 1 (4EBP1) and blocks translation by 68%.
-
GPI-1046
GPI-1046 is a non-immunosuppressive ligand of the immunophilin FKBP12.
-
WYE-354
WYE-354 is a potent, selective and ATP-competitive inhibitor of mTOR with IC50 of 5 nM (recombinant mTOR ).